JMIR Publications

Journal of Medical Internet Research

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 31.08.11 in Vol 13, No 3 (2011): Jul-Sep

This paper is in the following e-collection/theme issue:

Works citing "Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising"

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.1775):

(note that this is only a small subset of citations)

  1. Sullivan HW, O’Donoghue AC, Rupert DJ, Willoughby JF, Aikin KJ. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites. Journal of Health Communication 2017;22(2):171
    CrossRef
  2. Babar Z, Siraj AM, Curley L. A review of DTCA techniques: Appraising their success and potential impact on medication users. Research in Social and Administrative Pharmacy 2017;
    CrossRef
  3. Pinyopornpanish K, Jiraporncharoen W, Thaikla K, Yoonut K, Angkurawaranon C. Sedative and Analgesic Drugs Online: A Content Analysis of the Supply and Demand Information Available in Thailand. Substance Use & Misuse 2017;:1
    CrossRef
  4. Mackey TK, Kalyanam J, Katsuki T, Lanckriet G. Machine Learning to Detect Prescription Opioid Abuse Promotion and Access via Twitter. American Journal of Public Health 2017;:e1
    CrossRef
  5. Lopez CE, Mosquera S, Taype-Rondán . Direct to consumer advertising on websites of Peruvian naturopathic pharmacies. European Journal of Hospital Pharmacy 2017;24(3):194
    CrossRef
  6. Peiper NC, Baumgartner PM, Chew RF, Hsieh YP, Bieler GS, Bobashev GV, Siege C, Zarkin GA. Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California. Journal of Medical Internet Research 2017;19(7):e236
    CrossRef
  7. Ball JG, Manika D, Stout P. Causes and consequences of trust in direct-to-consumer prescription drug advertising. International Journal of Advertising 2016;35(2):216
    CrossRef
  8. Sullivan HW, O’Donoghue AC, Rupert DJ, Willoughby JF, Amoozegar JB, Aikin KJ. Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study. Journal of Health Communication 2016;21(11):1198
    CrossRef
  9. Huhmann BA, Limbu YB. Content and compliance of pharmaceutical social media marketing. Marketing Intelligence & Planning 2016;34(7):977
    CrossRef
  10. Anderson AC, Mackey TK, Attaran A, Liang BA. Mapping of Health Communication and Education Strategies Addressing the Public Health Dangers of Illicit Online Pharmacies. Journal of Health Communication 2016;21(4):397
    CrossRef
  11. Adams C. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis. Journal of Medical Internet Research 2016;18(2):e33
    CrossRef
  12. Southwell BG, Rupert DJ. Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(3):211
    CrossRef
  13. Mintzes B. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(5):329
    CrossRef
  14. Carpentier FRD. Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(4):283
    CrossRef
  15. Mackey TK, Schoenfeld VJ. Going “social” to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access. BMC Medicine 2016;14(1)
    CrossRef
  16. Mackey TK. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 2016;5(4):271
    CrossRef
  17. Koteyko N, Hunt D, Gunter B. Expectations in the field of the Internet and health: an analysis of claims about social networking sites in clinical literature. Sociology of Health & Illness 2015;37(3):468
    CrossRef
  18. Xu WW, Chiu I, Chen Y, Mukherjee T. Twitter hashtags for health: applying network and content analyses to understand the health knowledge sharing in a Twitter-based community of practice. Quality & Quantity 2015;49(4):1361
    CrossRef
  19. Kim H. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters. International Journal of Health Policy and Management 2015;4(12):813
    CrossRef
  20. Sullivan HW, Campbell M. Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration. Journal of Health Communication 2015;20(12):1391
    CrossRef
  21. Mackey TK, Cuomo RE, Liang BA. The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications. BMC Health Services Research 2015;15(1)
    CrossRef
  22. Mackey TK, Aung P, Liang BA. Illicit Internet availability of drugs subject to recall and patient safety consequences. International Journal of Clinical Pharmacy 2015;37(6):1076
    CrossRef
  23. Tyrawski J, DeAndrea DC. Pharmaceutical Companies and Their Drugs on Social Media: A Content Analysis of Drug Information on Popular Social Media Sites. Journal of Medical Internet Research 2015;17(6):e130
    CrossRef
  24. Mackey TK, Miner A, Cuomo RE. Exploring the e-cigarette e-commerce marketplace: Identifying Internet e-cigarette marketing characteristics and regulatory gaps. Drug and Alcohol Dependence 2015;156:97
    CrossRef
  25. Kornfield R, Alexander GC, Qato DM, Kim Y, Hirsch JD, Emery SL. Trends in Exposure to Televised Prescription Drug Advertising, 2003–2011. American Journal of Preventive Medicine 2015;48(5):575
    CrossRef
  26. Gibson S. Regulating Direct-to-Consumer Advertising of Prescription Drugs in the Digital Age. Laws 2014;3(3):410
    CrossRef
  27. Grajales III FJ, Sheps S, Ho K, Novak-Lauscher H, Eysenbach G. Social Media: A Review and Tutorial of Applications in Medicine and Health Care. Journal of Medical Internet Research 2014;16(2):e13
    CrossRef
  28. BINDHIM NF, NAICKER S, FREEMAN B, MCGEECHAN K, TREVENA L. Apps Promoting Illicit Drugs—A Need for Tighter Regulation?. Journal of Consumer Health On the Internet 2014;18(1):31
    CrossRef
  29. Mackey TK, Eysenbach G, Liang BA, Kohler JC, Geissbuhler A, Attaran A. A call for a moratorium on the .health generic top-level domain: preventing the commercialization and exclusive control of online health information. Globalization and Health 2014;10(1)
    CrossRef
  30. Scott Rader C, Subhan Z, D. Lanier C, Brooksbank R, Yankah S, Spears K. CyberRx. International Journal of Pharmaceutical and Healthcare Marketing 2014;8(2):193
    CrossRef
  31. Mackey TK, Yagi N, Liang BA. Prescription drug coupons: Evolution and need for regulation in direct-to-consumer advertising. Research in Social and Administrative Pharmacy 2014;10(3):588
    CrossRef
  32. Capurro D, Cole K, Echavarría MI, Joe J, Neogi T, Turner AM. The Use of Social Networking Sites for Public Health Practice and Research: A Systematic Review. Journal of Medical Internet Research 2014;16(3):e79
    CrossRef
  33. Muncy JA, Iyer R, Eastman JK. Medical advertising on demand: A content analysis of YouTube direct-to-consumer pharmaceutical advertisements. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 2014;14(2-3):145
    CrossRef
  34. Salimian PK, Chunara R, Weitzman ER. Averting the Perfect Storm: Addressing Youth Substance Use Risk From Social Media Use. Pediatric Annals 2014;43(10):411
    CrossRef
  35. Liang BA, Mackey TK, Lovett KM. Illegal “No Prescription” Internet Access to Narrow Therapeutic Index Drugs. Clinical Therapeutics 2013;35(5):694
    CrossRef
  36. Mackey TK, Liang BA. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Globalization and Health 2013;9(1):45
    CrossRef
  37. Wong H, Field KM, Shapiro JD, McKendrick JJ, Gibbs P. Financial Incentives in Cancer Care and Impact on Prescribing Practice. Journal of Clinical Oncology 2013;31(23):2973
    CrossRef
  38. Mackey TK, Liang BA, Strathdee SA. Digital Social Media, Youth, and Nonmedical Use of Prescription Drugs: The Need for Reform. Journal of Medical Internet Research 2013;15(7):e143
    CrossRef
  39. Wilson K, Keelan J. Social Media and the Empowering of Opponents of Medical Technologies: The Case of Anti-Vaccinationism. Journal of Medical Internet Research 2013;15(5):e103
    CrossRef
  40. Mackey TK, Liang BA. Global Reach of Direct-to-Consumer Advertising Using Social Media for Illicit Online Drug Sales. Journal of Medical Internet Research 2013;15(5):e105
    CrossRef
  41. Williams SA, Terras M, Warwick C. How Twitter Is Studied in the Medical Professions: A Classification of Twitter Papers Indexed in PubMed. Medicine 2.0 2013;2(2):e2
    CrossRef
  42. Abrahams SW. Milk and Social Media. Journal of Human Lactation 2012;28(3):400
    CrossRef
  43. Mackey TK, Liang BA. Transparency in Physician-Industry Relationships. Pathology Case Reviews 2012;17(4):144
    CrossRef
  44. Liang BA, Mackey TK. Vaccine shortages and suspect online pharmacy sellers. Vaccine 2012;30(2):105
    CrossRef
  45. Liang BA, Mackey TK, Lovett KM. Suspect online sellers and contraceptive access. Contraception 2012;86(5):551
    CrossRef
  46. Lau AY, Gabarron E, Fernandez-Luque L, Armayones M. Social Media in Health — What are the Safety Concerns for Health Consumers?. Health Information Management Journal 2012;41(2):30
    CrossRef
  47. Mackey TK, Liang BA. Separating online piracy from counterfeit medicines: The need for policy reform and a call to action. Health Policy and Technology 2012;1(3):120
    CrossRef
  48. Mackey TK, Liang BA. Oncology and the Internet: Regulatory Failure and Reform. Journal of Oncology Practice 2012;8(6):341
    CrossRef
  49. Liang BA, Mackey TK. Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics. Journal of Medical Internet Research 2012;14(1):e27
    CrossRef
  50. Liang BA, Mackey TK. Stem Cells, Dot-Com. Science Translational Medicine 2012;4(151):151cm9
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/jmir.1775)

:
  1. Adi A, Grigore G. Corporate Social Responsibility in the Digital Age. 2015. :143
    CrossRef